Your session is about to expire
← Back to Search
Other
Blood Pressure Cuff Inflation for Aortic Valve Surgery
N/A
Waitlist Available
Led By Pierre Voisine, MD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Planned isolated aortic valve replacement (stenosis based)
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6, 12, 24 and 48 hours post-operatively
Awards & highlights
Study Summary
This trial is testing whether a simple, non-invasive procedure can help protect the heart during surgery.
Who is the study for?
This trial is for adults over 18 who need an aortic valve replacement due to stenosis. It's not suitable for pregnant individuals, those with recent heart attacks, severe left ventricular dysfunction, endocarditis, previous sternotomy, limb deep vein thrombosis, emergency cases or certain other heart and kidney conditions.Check my eligibility
What is being tested?
The study tests if inflating a blood pressure cuff on the arm before surgery can protect the heart during aortic valve replacement. This non-invasive technique is called remote ischemic preconditioning.See study design
What are the potential side effects?
Potential side effects may include discomfort or bruising where the blood pressure cuff is applied. Since this procedure is non-invasive and localized, significant side effects are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a heart valve replacement due to narrowing.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6, 12, 24 and 48 hours post-operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6, 12, 24 and 48 hours post-operatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in biochemical markers of myocardial ischemia
Secondary outcome measures
Post-operative complications
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 200 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg. The ischemia-reperfusion cycle is performed 3 times for a total of 30 min. This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass.
Group II: Control groupActive Control1 Intervention
Sham remote ischemic preconditioning on the right arm is induced with a blood pressure cuff inflation at 20 mm Hg for 5 min and followed by a 5 min reperfusion at 0 mm Hg. The sham ischemia-reperfusion cycle is performed 3 times for a total of 30 min. This procedure is done after anesthetic induction, but before the patient is placed on cardiopulmonary bypass.
A 20 mm Hg blood pressure cuff on the right arm does not induce ischemia.
Find a Location
Who is running the clinical trial?
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecOTHER
36 Previous Clinical Trials
9,602 Total Patients Enrolled
4 Trials studying Aortic Valve Stenosis
625 Patients Enrolled for Aortic Valve Stenosis
Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,132 Total Patients Enrolled
4 Trials studying Aortic Valve Stenosis
870 Patients Enrolled for Aortic Valve Stenosis
Pierre Voisine, MDPrincipal InvestigatorUniversity Laval
2 Previous Clinical Trials
661 Total Patients Enrolled
1 Trials studying Aortic Valve Stenosis
251 Patients Enrolled for Aortic Valve Stenosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with significant blockage in my heart's arteries.I have undergone a TAVI procedure.I am scheduled for a heart valve replacement due to narrowing.I have a blood clot in a vein of my compressed limb.I am scheduled for a heart bypass surgery without using a heart-lung machine.My heart's left ventricle is not pumping well.I have chronic kidney problems or am on dialysis.I require an emergency medical procedure.I have undergone a MAZE procedure for my heart.I have had a heart attack in the last 7 days.I have had a previous open-heart surgery.I have been diagnosed with endocarditis.I am 18 years old or older.I have had heart bypass surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Control group
- Group 2: Intervention group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants still signing up for this research project?
"At present, this medical trial is not in search of participants. Initially posted on April 11th 2014 and last updated August 18th 2022; however, there are currently 179 other studies recruiting patients."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger